Role of baseline adenoma characteristics for adenoma recurrencein patients with high-risk adenoma

ÖZER SARI, Sevil; Solakoglu, Tevfik; Köseoğlu, Hüseyin; akın, fatma ebru; ERSOY, Osman; DEMİREZER BOLAT, Aylin; BÜYÜKAŞIK, Naciye Şemnur; TAYFUR YÜREKLİ, ÖYKÜ

Role of baseline adenoma characteristics for adenoma recurrencein patients with high-risk adenoma

TEVFİK SOLAKOĞLU, (Çorlu Devlet Hastanesi, Gastroenteroloji Bölümü, Tekirdağ, Türkiye)

Hüseyin KÖSEOĞLU, (Yıldırım Beyazıt Üniversitesi, Tıp Fakültesi, Gastroenteroloji Anabilim Dalı, Ankara, Türkiye)

Sevil ÖZER SARI, (Atatürk Eğitim ve Araştırma Hastanesi Gastroenteroloji Bölümü, Ankara, Türkiye)

Fatma Ebru AKIN, (Atatürk Eğitim ve Araştırma Hastanesi Gastroenteroloji Bölümü, Ankara, Türkiye)

Aylin DEMİREZER BOLAT, (Atatürk Eğitim ve Araştırma Hastanesi Gastroenteroloji Bölümü, Ankara, Türkiye)

Öykü TAYFUR YÜREKLİ, (Atatürk Eğitim ve Araştırma Hastanesi Gastroenteroloji Bölümü, Ankara, Türkiye)

Naciye Şemnur BÜYÜKAŞIK, (Atatürk Eğitim ve Araştırma Hastanesi Gastroenteroloji Bölümü, Ankara, Türkiye)

Osman ERSOY (Yıldırım Beyazıt Üniversitesi, Tıp Fakültesi, Gastroenteroloji Anabilim Dalı, Ankara, Türkiye)

Turkish Journal of Medical Sciences

1 0

Yıl: 2017 Cilt: 47 Sayı: 5 Sayfa Aralığı: 1416 - 1424 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Role of baseline adenoma characteristics for adenoma recurrencein patients with high-risk adenoma

Öz:

Background/aim: The present observational study aimed to determine the predictive value of 3-year recurrence adenoma characteristics at baseline conventional colonoscopy in patients with high-risk adenoma. Materials and methods: A total of 47 patients with high-risk adenoma at baseline colonoscopy were followed up and underwent a surveillance colonoscopy at 3 years. Correlations between adenoma recurrence and baseline adenoma characteristics (size, number, histological features, and location) were analyzed. Results: Among 135 patients with high-risk adenoma, 47 patients (35%) who underwent surveillance colonoscopy at 3 years following baseline colonoscopy were included in the study. In these 47 patients, at least one new adenoma was detected in 19 (40.4%) patients, and new advanced adenomas were detected in 5 (10.6%) patients during the surveillance colonoscopy. No significant difference was found in patients who had adenoma recurrence versus those who did not in terms of size of adenomas (P = 0.143), number of adenomas (P = 0.562), histological properties of adenomas (P = 0.658), or locations of adenomas (P = 0.567). Conclusion: Baseline adenoma characteristics were not associated with the recurrence of adenomas or advanced adenomas in patients with high-risk adenoma.

Anahtar Kelime:

Konular: Cerrahi

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA-Cancer J Clin 2011; 61: 69-90.
2. Qaseem A, Denberg TD, Hopkins RH Jr, Humphrey LL, Levine J, Sweet DE, Shekelle P. Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med 2012; 156: 378-386.
3. Pendergrass CJ, Edelstein DL, Hylind LM, Phillips BT, Iacobuzio-Donahue C, Romans K, Griffin CA, Cruz-Correa M, Tersmette AC, Offerhaus GJ et al. Occurrence of colorectal adenomas in younger adults: an epidemiologic necropsy study. Clin Gastroenterol H 2008; 6: 1011-1015.
4. Lee CS, Ronan L, OMorain C, McNamara D. Screening for colorectal cancer: what fits best? Expert Rev Gastroenterol Hepatol 2012; 6: 301-312.
5. Centers for Disease Control and Prevention. Vital signs: colorectal cancer screening, incidence, and mortality-United States, 2002-2010. MMWR Morb Mortal Wkly Rep 2011; 60: 884-889.
6. Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012; 143: 844-857.
7. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Results of screening colonoscopy among persons 40 to 49 years of age. New Engl J Med 2002; 346: 1781- 1785.
8. Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps; Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 2000; 95: 3053-3063.
9. Fearnhead NS, Wilding JL, Bodmer WF. Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis. Brit Med Bull 2002; 64: 27-43.
10. Cummings OW. Pathology of the adenoma-carcinoma sequence: from aberrant crypt focus to invasive carcinoma. Semin Gastrointest Dis 2000; 11: 229-237.
11. Risio M. Reprint of: the natural history of adenomas. Best Pract Res Clin Gastroenterol 2010; 24: 397-406.
12. de Jonge V, Sint Nicolaas J, van Leerdam ME, Kuipers EJ, Veldhuyzen van Zanten SJ. Systematic literature review and pooled analyses of risk factors for finding adenomas at surveillance colonoscopy. Endoscopy 2011; 43: 560-572.
13. Martínez ME, Baron JA, Lieberman DA, Schatzkin A, Lanza E, Winawer SJ, Zauber AG, Jiang R, Ahnen DJ, Bond JH et al. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology 2009; 136: 832-841.
14. Hamilton SR, Aaltonen LA. WHO Classification of Tumours: Pathology and Genetics of Tumours of the Digestive System. Lyon, France: IARC Press; 2000.
15. Winawer SJ. The achievements, impact, and future of the National Polyp Study. Gastrointest Endosc 2006; 64: 975-978.
16. Winawer SJ, Zauber AG, Ho MN, OBrien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF et al. Prevention of colorectal cancer by colonoscopic polypectomy. New Engl J Med 1993; 329: 1977-1981.
17. Winawer SJ, Zauber AG, OBrien MJ, Ho MN, Gottlieb L, Sternberg SS, Waye JD, Bond J, Schapiro M, Stewart ET et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. New Engl J Med 1993; 328: 901-906.
18. Strock P, Mossong J, Scheiden R. Colorectal cancer incidence is low in patients following a colonoscopy. Dig Liver Dis 2011; 43: 899-904.
19. Zauber AG, Winawer SJ, OBrien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, Shi W, Bond JH, Schapiro M, Panish JF et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. New Engl J Med 2012; 366: 687-696.
20. Kolligs FT, Crispin A, Munte A, Wagner A, Mansmann U, Göke B. Risk of advanced colorectal neoplasia according to age and gender. PLoS One 2011; 6: e20076.
21. van Heijningen EM, Lansdorp-Vogelaar I, Kuipers EJ, Dekker E, Lesterhuis W, Ter Borg F, Vecht J, De Jonge V, Spoelstra P, Engels L et al. Features of adenoma and colonoscopy associated with recurrent colorectal neoplasia based on a large community-based study. Gastroenterology 2013; 144: 1410- 1418.
22. Jørgensen OD, Kronborg O, Fenger C. A randomized surveillance study of patients with pedunculated and small sessile tubular and tubulovillous adenomas: The Funen Adenoma Follow-up Study. Scand J Gastroenterol 1995; 30: 686-692.
23. Bertario L, Russo A, Sala P, Pizzetti P, Ballardini G, Andreola S, Spinelli P. Predictors of metachronous colorectal neoplasms in sporadic adenoma patients. Int J Cancer 2003; 105: 82-87.
24. Ji JS, Choi KY, Lee WC, Lee BI, Park SH, Choi H, Kim BW, Chae HS, Park YM, Park YJ. Endoscopic and histopathologic predictors of recurrence of colorectal adenoma on lowering the miss rate. Korean J Intern Med 2009; 24: 196-202.
25. Van Stolk RU, Beck GJ, Baron JA, Haile R, Summers R. Adenoma characteristics at first colonoscopy as predictors of adenoma recurrence and characteristics at follow-up. Gastroenterology 1998; 115: 13-18.
26. Laiyemo AO, Murphy G, Albert PS, Sansbury LB, Wang Z, Cross AJ, Marcus PM, Caan B, Marshall JR, Lance P et al. Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years. Ann Intern Med 2008; 148: 419-426.
27. Lieberman DA, Weiss DG, Harford WV, Ahnen DJ, Provenzale D, Sontag SJ, Schnell TG, Chejfec G, Campbell DR, Kidao J et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology 2007; 133: 1077-1085.
28. Nusko G, Hahn EG, Mansmann U. Risk of advanced metachronous colorectal adenoma during long-term followup. Int J Colorectal Dis 2008; 23: 1065-1071.
29. Noshirwani KC, van Stolk RU, Rybicki LA, Beck GJ. Adenoma size and number are predictive of adenoma recurrence: implications for surveillance colonoscopy. Gastrointest Endosc 2000; 51: 433-437.
30. Imperiale TF, Glowinski EA, Lin-Cooper C, Larkin GN, Rogge JD, Ransohoff DF. Five-year risk of colorectal neoplasia after negative screening colonoscopy. New Engl J Med 2008; 359: 1218-1224.
31. Bonithon-Kopp C, Piard F, Fenger C, Cabeza E, OMorain C, Kronborg O, Faivre J. Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum 2004; 47: 323-333.
32. Martínez ME, Sampliner R, Marshall JR, Bhattacharyya AK, Reid ME, Alberts DS. Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology 2001; 120: 1077-1083.
33. Chung SJ, Kim YS, Yang SY, Song JH, Kim D, Park MJ, Kim SG, Song IS, Kim JS. Five-year risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prospective study in 2452 asymptomatic Koreans. Gut 2011; 60: 1537-1543.
34. Rosa I, Fidalgo P, Soares J, Vinga S, Oliveira C, Silva JP, Ferro SM, Chaves P, Oliveira AG, Leitão CN. Adenoma incidence decreases under the effect of polypectomy. World J Gastroenterol 2012; 18: 1243-1248.
35. Triantafyllou K, Papatheodoridis GV, Paspatis GA, Vasilakaki TH, Elemenoglou I, Karamanolis DG. Predictors of the early development of advanced metachronous colon adenomas. Hepatogastroenterology 1997; 44: 533-538.
36. Lorenzo-Zúñiga V, Moreno de Vega V, Domènech E, Mañosa M, Cabré E, Planas R, Boix J. High-definition colonoscopy and risk factors for recurrence of advanced adenomas in patients with a personal history of polyps. Eur J Gastroenterol Hepatol 2011; 23: 425-430.

APA	Solakoglu T, Köseoğlu H, ÖZER SARI S, akın f, DEMİREZER BOLAT A, TAYFUR YÜREKLİ Ö, BÜYÜKAŞIK N, ERSOY O (2017). Role of baseline adenoma characteristics for adenoma recurrencein patients with high-risk adenoma. , 1416 - 1424.
Chicago	Solakoglu Tevfik,Köseoğlu Hüseyin,ÖZER SARI Sevil,akın fatma ebru,DEMİREZER BOLAT Aylin,TAYFUR YÜREKLİ ÖYKÜ,BÜYÜKAŞIK Naciye Şemnur,ERSOY Osman Role of baseline adenoma characteristics for adenoma recurrencein patients with high-risk adenoma. (2017): 1416 - 1424.
MLA	Solakoglu Tevfik,Köseoğlu Hüseyin,ÖZER SARI Sevil,akın fatma ebru,DEMİREZER BOLAT Aylin,TAYFUR YÜREKLİ ÖYKÜ,BÜYÜKAŞIK Naciye Şemnur,ERSOY Osman Role of baseline adenoma characteristics for adenoma recurrencein patients with high-risk adenoma. , 2017, ss.1416 - 1424.
AMA	Solakoglu T,Köseoğlu H,ÖZER SARI S,akın f,DEMİREZER BOLAT A,TAYFUR YÜREKLİ Ö,BÜYÜKAŞIK N,ERSOY O Role of baseline adenoma characteristics for adenoma recurrencein patients with high-risk adenoma. . 2017; 1416 - 1424.
Vancouver	Solakoglu T,Köseoğlu H,ÖZER SARI S,akın f,DEMİREZER BOLAT A,TAYFUR YÜREKLİ Ö,BÜYÜKAŞIK N,ERSOY O Role of baseline adenoma characteristics for adenoma recurrencein patients with high-risk adenoma. . 2017; 1416 - 1424.
IEEE	Solakoglu T,Köseoğlu H,ÖZER SARI S,akın f,DEMİREZER BOLAT A,TAYFUR YÜREKLİ Ö,BÜYÜKAŞIK N,ERSOY O "Role of baseline adenoma characteristics for adenoma recurrencein patients with high-risk adenoma." , ss.1416 - 1424, 2017.
ISNAD	Solakoglu, Tevfik vd. "Role of baseline adenoma characteristics for adenoma recurrencein patients with high-risk adenoma". (2017), 1416-1424.

APA	Solakoglu T, Köseoğlu H, ÖZER SARI S, akın f, DEMİREZER BOLAT A, TAYFUR YÜREKLİ Ö, BÜYÜKAŞIK N, ERSOY O (2017). Role of baseline adenoma characteristics for adenoma recurrencein patients with high-risk adenoma. Turkish Journal of Medical Sciences, 47(5), 1416 - 1424.
Chicago	Solakoglu Tevfik,Köseoğlu Hüseyin,ÖZER SARI Sevil,akın fatma ebru,DEMİREZER BOLAT Aylin,TAYFUR YÜREKLİ ÖYKÜ,BÜYÜKAŞIK Naciye Şemnur,ERSOY Osman Role of baseline adenoma characteristics for adenoma recurrencein patients with high-risk adenoma. Turkish Journal of Medical Sciences 47, no.5 (2017): 1416 - 1424.
MLA	Solakoglu Tevfik,Köseoğlu Hüseyin,ÖZER SARI Sevil,akın fatma ebru,DEMİREZER BOLAT Aylin,TAYFUR YÜREKLİ ÖYKÜ,BÜYÜKAŞIK Naciye Şemnur,ERSOY Osman Role of baseline adenoma characteristics for adenoma recurrencein patients with high-risk adenoma. Turkish Journal of Medical Sciences, vol.47, no.5, 2017, ss.1416 - 1424.
AMA	Solakoglu T,Köseoğlu H,ÖZER SARI S,akın f,DEMİREZER BOLAT A,TAYFUR YÜREKLİ Ö,BÜYÜKAŞIK N,ERSOY O Role of baseline adenoma characteristics for adenoma recurrencein patients with high-risk adenoma. Turkish Journal of Medical Sciences. 2017; 47(5): 1416 - 1424.
Vancouver	Solakoglu T,Köseoğlu H,ÖZER SARI S,akın f,DEMİREZER BOLAT A,TAYFUR YÜREKLİ Ö,BÜYÜKAŞIK N,ERSOY O Role of baseline adenoma characteristics for adenoma recurrencein patients with high-risk adenoma. Turkish Journal of Medical Sciences. 2017; 47(5): 1416 - 1424.
IEEE	Solakoglu T,Köseoğlu H,ÖZER SARI S,akın f,DEMİREZER BOLAT A,TAYFUR YÜREKLİ Ö,BÜYÜKAŞIK N,ERSOY O "Role of baseline adenoma characteristics for adenoma recurrencein patients with high-risk adenoma." Turkish Journal of Medical Sciences, 47, ss.1416 - 1424, 2017.
ISNAD	Solakoglu, Tevfik vd. "Role of baseline adenoma characteristics for adenoma recurrencein patients with high-risk adenoma". Turkish Journal of Medical Sciences 47/5 (2017), 1416-1424.